Page last updated: 2024-11-02

oxidopamine and Teratocarcinoma

oxidopamine has been researched along with Teratocarcinoma in 2 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Teratocarcinoma: A malignant neoplasm consisting of elements of teratoma with those of embryonal carcinoma or choriocarcinoma, or both. It occurs most often in the testis. (Dorland, 27th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, KA2
Mendez, I2
Hong, M1
Sadi, D1

Other Studies

2 other studies available for oxidopamine and Teratocarcinoma

ArticleYear
Long distance selective fiber outgrowth of transplanted hNT neurons in white matter tracts of the adult rat brain.
    The Journal of comparative neurology, 2005, Jun-13, Volume: 486, Issue:4

    Topics: Adrenergic Agents; Amphetamine; Animals; Axons; Behavior, Animal; Cell Differentiation; Cell Line, T

2005
Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease.
    Experimental neurology, 2000, Volume: 162, Issue:2

    Topics: Amphetamine; Animals; Cell Count; Cell Line; Corpus Striatum; Disease Models, Animal; Dopamine; Fema

2000